NVO vs REGN: Which Stock is Better?
Side-by-side comparison of Novo Nordisk A S and Regeneron Pharmaceuticals Inc in 2026
NVO
Novo Nordisk A S
$37.45
REGN
Regeneron Pharmaceuticals Inc
$781.67
Key Metrics Comparison
| Metric | NVO | REGN | Winner |
|---|---|---|---|
| Market Cap | $166.46B | $82.64B | NVO |
| P/E Ratio | 10.29 | 18.83 | NVO |
| EPS (TTM) | $3.64 | $41.51 | REGN |
| Revenue Growth | -0.1% | 0.0% | REGN |
| Gross Margin | 82.4% | 44.6% | NVO |
Analyze NVO
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is NVO or REGN a better investment?
Comparing NVO and REGN: Novo Nordisk A S has a market cap of $166.46B while Regeneron Pharmaceuticals Inc has $82.64B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between NVO and REGN?
NVO (Novo Nordisk A S) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: NVO or REGN?
Based on P/E ratios, NVO trades at a lower multiple (10.3x vs 18.8x).
Which is growing faster: NVO or REGN?
REGN has higher revenue growth at 0.0% vs -0.1% for NVO.
Which company is more profitable: NVO or REGN?
Novo Nordisk A S (NVO) has higher gross margins at 82.4% compared to 44.6% for REGN.
Which is the larger company: NVO or REGN?
Novo Nordisk A S (NVO) is larger with a market cap of $166.46B compared to $82.64B for REGN.
Should I buy NVO or REGN in 2026?
Both NVO and REGN have investment merit. NVO trades at $37.45 while REGN trades at $781.67. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between NVO and REGN stock?
Key differences: Market Cap ($166.46B vs $82.64B), P/E Ratio (10.3x vs 18.8x), Revenue Growth (-0.1% vs 0.0%), Gross Margin (82.4% vs 44.6%).